Let's spread the word about Immunotherapy! Click to share this page with your community.

Immuno-Oncology: A Future Look

This intimate, invitation-only event for media and health care investment analysts is hosted by Cancer Research Institute at the New York Academy of Sciences. It features both a panel of leading academic scientific experts in immunotherapy, including 2018 Nobel Prize winner and Director of CRI’s Scientific Advisory Council, Dr. James P. Allison, and a fireside chat with chief science officers representing pharma and biotech leaders to share their points of view on what’s next in the IO field.

Watch a Recording of Immuno-Oncology: A Future Look

Read a Recap of Immuno-Oncology: A Future Look

When

Friday, June 21, 2019
Registration: 9am
Panel Sessions: 10am-12pm
Lunch Reception: 12pm

Where

The New York Academy of Sciences
7 World Trade Center
250 Greenwich Street, Floor 40
New York, NY 10007

Academic Panel

James P. Allison, Ph.D.James P. Allison, Ph.D., 2018 Nobel Laureate
Chair, Department of Immunology, University of Texas MD Anderson Cancer Center

 

Phil Greenberg, M.D.Philip D. Greenberg, M.D.
Head of Immunology, Fred Hutchinson Cancer Research Center

 

Robert H. Vonderheide, M.D., D.Phil.Robert H. Vonderheide, M.D., D.Phil.
Director, Abramson Cancer Center, University of Pennsylvania

 

Jill O'Donnell-Tormey, Ph.D.Jill O'Donnell-Tormey, Ph.D. (Moderator)
CEO and Director of Scientific Affairs, Cancer Research Institute

 

Industry Fireside Chat

Awny Farajallah, M.D., FACPAwny Farajallah, M.D., FACP
Vice President, Head U.S. Medical, Bristol-Myers Squibb

 

George D. Yancopoulos, M.D., Ph.D.George D. Yancopoulos, M.D., Ph.D.
Founder, President, and Chief Scientific Officer, Regeneron

 

Meg Tirrell ReporterMeg Tirrell (Moderator)
Reporter, Biotechnology and Pharmaceuticals, CNBC

 

Opening Remarks

Andrew TsaiAndrew K. Tsai
Co-Chairman, CRI Board of Trustees
Co-Founder and Chief Investment Officer, Chalkstream Capital Group

*Immunotherapy results may vary from patient to patient.

Top